ISRCTN57714676已完成不适用
Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose comparison
Swiss Tropical and Public Health Institute (Switzerland)0 个研究点目标入组 308 人开始时间: 2011年5月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 308
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. School children (males and females) between 6-16 years
排除标准
- •1. Pregnancy
- •2. Severe illness
- •3. Non-consent
研究者
相似试验
已完成
3 期
Schistosoma Haematobium Infections and PraziquantelSchistosomiasisNCT01558336University of Khartoum520
已完成
2 期
Efficacy and safety of Praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adultsMalariaPACTR20220658481795144
Unknown
不适用
Optimization of Schistosomiasis treatment in TanzaniaSschistosomiasisMalariaPACTR201612001914353Muhumbili University of Health and Allied Sciences600
已完成
不适用
Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients infected with Clonorchis sinensisClonorchiasisInfections and InfestationsISRCTN55086560The National Institute of Parasitic Diseases (China)120
已完成
2 期
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)NeurocysticercosisEpilepsyNCT00441285Universidad Peruana Cayetano Heredia156